Applications of (2R,3S)-3-Phenylisoserine Hydrochloride in Industrial Manufacturing

As a producer of (2R,3S)-3-Phenylisoserine Hydrochloride, we supply this key chiral intermediate to multiple industries that require highly selective and reliable raw materials for active molecule assembly. Our optimized production and QA systems ensure every batch supports strict compliance across major regulated manufacturing environments.

1. Pharmaceutical API Synthesis – Antineoplastic Agents

Our material is widely used for the stereoselective synthesis of taxane-derived antitumor agents, including the preparation of side chains for docetaxel and paclitaxel. Innovator and generic drug manufacturers rely on this intermediate to meet stringent impurity and stereoisomeric purity demands. The compound enters the synthesis during coupling steps to introduce chirality and functional groups in the final API. Manufacturing follows route-specific protocols with in-process control to ensure yield and isomer consistency. Buyers formulate the intermediate typically in a protected or salt form, adjusted based on the specific synthesis stage and compatibility with reagents.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• US FDA 21 CFR Part 210/211: GMP for Finished Pharmaceuticals
• ICH Q3A/B: Impurities in New Drug Substances and Products
• EDQM CEP, DMF registration for pharmaceutical intermediates

Typical usage ratio

• Ranges from 0.8 to 1.2 molar equivalents per API synthesis batch; adjusted according to molar balance with taxane core input and step-specific requirements for protection or salt conversion yields

Downstream process integration

• Enters as a key coupling partner in the side-chain synthesis pre-API stage
• Undergoes esterification/amination followed by chiral preservation and final API conversion

Final product types

• Docetaxel (Taxotere®) API
• Paclitaxel (Taxol®) API
• Advanced taxane derivatives under development or as patent-expired oncology agents

2. Chiral Building Block for Custom Peptide Synthesis

Leading peptide contract manufacturers use (2R,3S)-3-Phenylisoserine Hydrochloride to introduce specific stereochemistry in peptide segments for use in oncology and immunology research. The compound is incorporated via solution-phase and solid-phase peptide synthesis (SPPS) routes, with customized protection schemes as required for N- and C-terminus extensions. Our material integrates at defined sequence locations, contributing to desired three-dimensional folding and bioactivity of the resulting therapeutic candidate.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for chemical manufacturing
• USP General Chapters <1045>: Biotechnology-Derived Articles
• European Pharmacopoeia (Ph. Eur.) Monographs where applicable
• FDA Guidance for Industry: Quality Considerations in Peptide Drug Development

Typical usage ratio

• Typically 1 equivalent per insertion, proportional to chain elongation cycles; final concentration depends on target peptide length and complexity

Downstream process integration

• Incorporated during the elongation steps of SPPS as a protected amino acid analog
• Used in coupling exchanges requiring high stereochemical integrity

Final product types

• Peptide-based therapeutic APIs for clinical research
• Research-grade custom peptides for pharmaceutical screening
• Peptidomimetic compounds under preclinical evaluation

3. Fine Chemical Intermediate for Advanced Organic Synthesis

Major fine chemical producers incorporate our chiral amino acid derivative to construct architecturally complex molecules used for new drug candidates, specialty surfactants, and advanced monomers. Synthesis projects utilize the hydrochloride salt for its solution stability and reactivity during selective transformations including amidations, esterifications, and asymmetric reductions. The compound acts at an early or intermediate stage, and its configuration enables downstream formation of target structures without racemization. We supply process-optimized lots to facilitate scale-up or multi-step continuous flow reactions.

Industry compliance standards

• REACH Regulation (EC) No 1907/2006 for registered intermediates
• ISO 14001:2015 Environmental Management Systems
• Local site-specific HSE and chemical control regulations (e.g., Seveso Directive for on-site chemical handling)
• Customer project-specific quality audit requirements

Typical usage ratio

• 0.5 to 2.0 equivalents per transformation step depending on downstream reaction yield; ratio optimized to the specific synthetic scheme

Downstream process integration

• Fed as a chiral precursor at early transformation or for late-stage functionalization during molecule assembly
• Enters amidation or esterification steps under anhydrous or controlled aqueous conditions

Final product types

• Pharmaceutical discovery intermediates
• Specialty surfactant monomers
• Chiral ligands and catalysts for asymmetric catalysis

4. Reference Standard Production for Analytical Laboratories

Analytical and reference material manufacturers use our high-purity (2R,3S)-3-Phenylisoserine Hydrochloride as a key material for producing analytical standards and impurity markers. These standards serve in pharmaceutical QC, regulatory method validation, and academic research. We provide material that meets strict documentation and traceability requirements for lot identity, homogeneity, and impurity profiling. Users further purify and formulate this compound for end-use as certified reference materials and calibrators within regulated testing environments.

Industry compliance standards

• ISO 17034:2016 General Requirements for the Competence of Reference Material Producers
• ISO/IEC 17025:2017 Testing and Calibration Laboratories
• Pharmacopoeial requirements for analytical reference standards (Ph. Eur., USP, JP)
• OECD Good Laboratory Practice (GLP) for QC and analytical use

Typical usage ratio

• Prepared as pure standard quantities from 1 mg to 100 g depending on lot size and calibration frequency; diluted to ppb–ppm levels for lab use as specified in method SOPs

Downstream process integration

• Purified and characterized for qualification as primary or secondary standard
• Packaged into ampoules or vials for calibration kit assembly and distribution

Final product types

• Certified reference materials for HPLC or GC analysis
• Reference impurity standards for pharmaceutical QC
• Calibrators for regulatory method validation